Russ Altman

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by 50.53.1.33 (talk) at 21:43, 4 November 2016 (→‎References). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Russ Biagio Altman
Russ Altman speaking at ISMB 2014.
Alma materHarvard College
Stanford University
Known forPharmGKB[2]
AwardsISCB Fellow (2010)
Scientific career
InstitutionsStanford University
Thesis Exclusion Methods for the Determination of Protein Structure from Experimental Data  (1989)
Doctoral studentsOlga Troyanskaya[1]

Russ Biagio Altman is a scientist at Stanford University Medical School,[3] where he is chair of the department of Bioengineering and director of the program in Biomedical Informatics.[4][5][6] He is a past president and one of the founding members of the International Society for Computational Biology.

External videos
video icon What really happens when you mix medications?, 14:41, TED talks[7]

He is also an attending physician in Menlo Park, California, and is the principal investigator for the PharmGKB knowledge-base.[2][8]

In February 2006, Altman gave a presentation at Google, in which he explained the opportunities for pharmacogenomics.[9] In August 2007, Altman was interviewed by Kromosoft, in which he discussed the emerging trends in pharmacogenomics.[10] On November 2, 2007, Altman delivered the IEEE Computer Society's BioInformatics and BioMedicine (BIBM) conference keynote lecture on combining simulation and machine learning to recognize function in 4D.[11] Altman is North American Associate Editor of Briefings in Bioinformatics and an honorary consulting editor for the International Society of Intelligent Biological Medicine, and in 2010 was elected as a fellow for the International Society for Computational Biology.[12] Altman is currently the principal investigator of the Iranian Genome Project, at www.irangenes.com.

Education

Altman received his AB in Biochemistry and Molecular Biology in 1983 from Harvard College,[13] his PhD in Medical Information Sciences from Stanford in 1989 and his MD also from Stanford in 1990.[14]

References

  1. ^ Mullins, J.; Morrison Mckay, B. (2011). "International Society for Computational Biology Honors Michael Ashburner and Olga Troyanskaya with Top Bioinformatics/Computational Biology Awards for 2011". PLoS Computational Biology. 7 (6): e1002081. doi:10.1371/journal.pcbi.1002081. PMC 3107244.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  2. ^ a b Altman, R. B. (2007). "PharmGKB: A logical home for knowledge relating genotype to drug response phenotype". Nature Genetics. 39 (4): 426–426. doi:10.1038/ng0407-426. PMC 3203536. PMID 17392795.
  3. ^ Russ Altman, MD, PhD
  4. ^ Troyanskaya, O.; Cantor, M.; Sherlock, G.; Brown, P.; Hastie, T.; Tibshirani, R.; Botstein, D.; Altman, R. (2001). "Missing value estimation methods for DNA microarrays". Bioinformatics. 17 (6): 520–525. doi:10.1093/bioinformatics/17.6.520. PMID 11395428.
  5. ^ Garber, M. E.; Troyanskaya, O. G.; Schluens, K.; Petersen, S.; Thaesler, Z.; Pacyna-Gengelbach, M.; Van De Rijn, M.; Rosen, G. D.; Perou, C. M.; Whyte, R. I.; Altman, R. B.; Brown, P. O.; Botstein, D.; Petersen, I. (2001). "Diversity of gene expression in adenocarcinoma of the lung". Proceedings of the National Academy of Sciences. 98 (24): 13784–13789. Bibcode:2001PNAS...9813784G. doi:10.1073/pnas.241500798.
  6. ^ Raychaudhuri, S.; Stuart, J.; Altman, R. (2000). "Principal components analysis to summarize microarray experiments: Application to sporulation time series". Pacific Symposium on Biocomputing: 455–466. PMC 2669932. PMID 10902193.
  7. ^ "What really happens when you mix medications?". TED (talks). Retrieved April 2, 2016.
  8. ^ "PharmGKB: The Pharmacogenetics and Pharmacogenomics Knowledge Base". Archived from the original on 2006-04-19. Retrieved 2007-09-06. {{cite news}}: Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  9. ^ "Opportunities For Pharmacogenomics and Personalized Medicine". Retrieved 2007-09-06.
  10. ^ "Current and Emerging Trends in Pharmacogenomics". Retrieved 2007-09-06.
  11. ^ Halperin, I.; Glazer, D. S.; Wu, S.; Altman, R. B. (2008). "The FEATURE framework for protein function annotation: Modeling new functions, improving performance, and extending to novel applications". BMC Genomics. 9: S2. doi:10.1186/1471-2164-9-S2-S2.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  12. ^ http://www.iscb.org/iscb-fellows
  13. ^ Altman, R.; Ladner, J.; Lipscomb, W. (1982). "Quaternary structural changes in aspartate carbamoyltransferase of Escherichia coli at pH 8.3 and pH 5.8". Biochemical and Biophysical Research Communications. 108 (2): 592–595. doi:10.1016/0006-291X(82)90869-5. PMID 6756403.
  14. ^ https://med.stanford.edu/profiles/frdActionServlet?choiceId=facProfile&fid=4706 Russ Altman, Community Academic Profile
Preceded by President of the
International Society for Computational Biology
2000 – 2002 		Succeeded by
Retrieved from "https://en.wikipedia.org/w/index.php?title=Russ_Altman&oldid=747870930"